Preoperative Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Stage I-III Gastric Cancer Patients with a MGC Component

Table 2

The clinicopathological characteristics of 336 patients with gastric cancer.

Variables	(165 cases)	(171 cases)	X2 value	value
Sex			1.221	0.296
Male	121	116
Female	44	55
Age (years)			0.316	0.574
<59	76	84
≥59	89	87
mMGC/pMGC			0.889	0.346
mMGC	116	112
pMGC	49	59
Tumor size (cm)			12.861	<0.001
<5.25	91	61
≥5.25	74	110
Chemotherapy			2.427	0.119
Yes	69	86
No	96	85
R0/R1&2 resection			2.594	0.107
R0	143	137
R1/R2	22	34
pT			15.887	0.001
T1	15	3
T2	25	12
T3	19	24
T4	106	132
pN			15.730	0.003
N0	45	27
N1	35	28
N2	39	38
N3a	33	45
N3b	13	33
pTNM			12.523	<0.001
I+II	65	37
III	100	134
Tumor location			12.906	0.024
L	109	86
M	16	31
U	18	17
LM	13	25
MU	6	5
LMU	3	7
Leukocyte			3.768	0.052
<6.17	82	103
≥6.17	83	68
Neutrophil			2.609	0.106
<3.31	83	71
≥3.31	82	100
Hemoglobin			35.619	<0.001
<125.1	46	103
≥125.1	119	68
Fibrinogen			10.791	0.001
<3.31	100	73
≥3.31	65	98
Albumin			4.031	0.045
<40.1	65	86
≥40.1	100	85
Globulin			2.121	0.145
<29.2	119	135
≥29.2	46	36
Platelet			60.100	<0.001
<243	119	51
≥243	46	120
Total gastrectomy			10.402	0.001
Yes	32	60
No	133	111
NLR			56.385	<0.001
<1.6	88	25
≥1.6	77	146

; L = lower; M = middle; U = upper; NLR = neutrophil-to-lymphocyte ratio; MGC = mucinous gastric carcinoma.